Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study.

Conclusions. The recurrence rate of ROP in Zone II Stage 3+ after initial ranibizumab treatment was notable and preretinal hemorrhage before treatment was associated with the recurrence of ROP in our study. PMID: 28491468 [PubMed - in process]
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research